BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28712967)

  • 1. Clinical utility of the Calgary Depression Scale for Schizophrenia in individuals at ultra-high risk of psychosis.
    Rekhi G; Ng WY; Lee J
    Schizophr Res; 2018 Mar; 193():423-427. PubMed ID: 28712967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
    Addington J; Shah H; Liu L; Addington D
    Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis.
    Yang Z; Lim K; Lam M; Keefe R; Lee J
    Schizophr Res; 2018 Nov; 201():85-90. PubMed ID: 29804925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychometric properties of French version of the Calgary depression scale for schizophrenics (CDSS)].
    Reine G; Bernard D; Auquier P; Le Fur B; Lançon C
    Encephale; 2000; 26(1):52-61. PubMed ID: 10875062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Grover S; Sahoo S; Dua D; Chakrabarti S; Avasthi A
    Psychiatry Res; 2017 Jun; 252():333-339. PubMed ID: 28315621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Psychometric Properties and the Factor Structure of the Calgary Depression Scale for Schizophrenia Across the Schizotypy Continuum.
    Monsonet M; Kwapil TR; Barrantes-Vidal N
    Assessment; 2022 Jun; 29(4):686-699. PubMed ID: 33522263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of depression in schizophrenia: psychometric properties of a French version of the Calgary Depression Scale.
    Lançon C; Auquier P; Reine G; Toumi M; Addington D
    Psychiatry Res; 1999 Dec; 89(2):123-32. PubMed ID: 10646831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guilt and depression: two different factors in individuals with negative symptoms of schizophrenia.
    Rabany L; Weiser M; Levkovitz Y
    Eur Psychiatry; 2013 Aug; 28(6):327-31. PubMed ID: 23021933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Calgary Depression Rating Scale for schizophrenia in a healthy control group: psychometric properties and reference values.
    Müller MJ; Brening H; Gensch C; Klinga J; Kienzle B; Müller KM
    J Affect Disord; 2005 Sep; 88(1):69-74. PubMed ID: 16040126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Schennach R; Obermeier M; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M; Möller HJ
    Psychopathology; 2012; 45(5):276-85. PubMed ID: 22796716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.
    Bressan RA; Chaves AC; Shirakawa I; de Mari J
    Schizophr Res; 1998 Jun; 32(1):41-9. PubMed ID: 9690333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.
    Bernard D; Lançon C; Auquier P; Reine G; Addington D
    Acta Psychiatr Scand; 1998 Jan; 97(1):36-41. PubMed ID: 9504701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis.
    Soyata AZ; Akışık S; İnhanlı D; Noyan H; Üçok A
    Psychiatry Res; 2018 Mar; 261():332-337. PubMed ID: 29334657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
    Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.